Trial Details

COMPLETED
Basic Information
Clinical ID c4642
Identifier NCT00209300
Trial Title Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Pentasa
Participant Information
Sponsor Ferring Pharmaceuticals
City Brussels
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2005-05
Primary Completion Date 2007-05
Completion Date 2007-06